Endometrial Neoplasms  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00071929: Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

Completed
2
US
oxaliplatin
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Cancer
 
09/07

Download Options